RecruitingNCT05689190
Non-invasive Flow Measurements in Patients With Lower Extremity Arterial Disease (LEAD)
Sponsor
Philips Clinical & Medical Affairs Global
Enrollment
30 participants
Start Date
Apr 25, 2023
Study Type
OBSERVATIONAL
Conditions
Summary
This concerns a study with patients who will undergo endovascular treatment. Blood flow will be measured by 2D Duplex Ultrasound. Contrast data will be collected that will be processed offline.
Eligibility
Min Age: 18 Years
Inclusion Criteria5
- Patients referred to the vascular surgery outpatient clinic (LUMC) with PAD
- Age ≥18 years
- Superficial femoral artery (SFA) stenosis (>70% occluded)
- Elective for a percutaneous transluminal angioplasty procedure
- Written informed consent
Exclusion Criteria2
- Contraindications to angiography, such as severe renal insufficiency (eGFR< 20)
- Non-correctable bleeding disorder.
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05689190